More on PTGX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (10.0 Score)
- Holders

Upcoming Events

- Earnings (7/30/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Protagonist Therapeutics (NQ:PTGX)
Delayed: 140.91 +8.89 (6.73%)
Prev. Close $132.02  
Open$131.37 
52 Wk High$24.52 
52 Wk Low$10.02 
Day High$141.08 
Day Low$131.37 
P/E N/A  
EPS$0.00 
Volume519,117 

Friends, Peers and Foes (?): JNJ TAK (more...)

Jul 17, 2026 05:06 AM Protagonist Therapeutics (PTGX) PT Raised to $165 at Citizens as Icotyde Revenue Ramps
Jul 16, 2026 04:05 PM Protagonist Therapeutics Reports Granting of Inducement Awards
Jul 14, 2026 05:13 AM Protagonist Therapeutics (PTGX) PT Raised to $151 at Barclays
Jul 7, 2026 06:03 AM Protagonist Therapeutics (PTGX) PT Raised to $145 at Truist Securities
Jul 1, 2026 04:06 PM Protagonist Therapeutics Reports Granting of Inducement Awards
Jul 1, 2026 09:13 AM TD Cowen Reiterates Buy Rating on Protagonist Therapeutics (PTGX)
Jun 25, 2026 04:10 PM Form 4 Protagonist Therapeutics For: Jun 23 Filed by: Waddill William D.
Jun 23, 2026 04:27 PM Form 144 Protagonist Therapeutics Filed by: Waddill William D.
Jun 18, 2026 04:31 PM Form 8-K Protagonist Therapeutics For: Jun 17
Jun 16, 2026 04:01 PM Protagonist Therapeutics Reports Granting of Inducement Awards
View All Articles

Entities mentioned with PTGX

View All Entities